OTCMKTS:FCPG First China Pharmaceutical Group (FCPG) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About First China Pharmaceutical Group Stock (OTCMKTS:FCPG) 30 days 90 days 365 days Advanced Chart Remove Ads Get FCPG alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume15,858 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewFirst China Pharmaceutical Group, Inc. operates through its wholly owned subsidiary Kun Ming Xin Yuan Tang Pharmacies Co. Ltd. (XYT) is engaged in drug logistics and distribution in Yunnan Province, China through drug stores, medical clinics and hospitals. XYT is a provincial pharmaceutical distributor that offers approximately 5,000 drugs, of which approximately 1,000 are over-the-counter drugs, approximately 1,000 are prescription drugs, approximately 2,000 are prepared Chinese medicines and approximately 1,000 are supplements. The Company's short term objective is to broaden its product line from 5,000 products to 30,000 and include significantly more Western medicines as well as traditional Chinese drugs and herbs. By expanding its product line six-fold and offering products at a lower price than major competitors, the Company expects to be able to become its customers' primary distributor, supplying more than 80% of the pharmaceutical products they require.Read More… Remove Ads Receive FCPG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for First China Pharmaceutical Group and its competitors with MarketBeat's FREE daily newsletter. Email Address FCPG Stock News HeadlinesAstraZeneca Says Current, Former Executives Involved in China ProbeNovember 7, 2024 | msn.comGOP senators eye comprehensive China strategy to curb CCP influenceSeptember 26, 2024 | foxnews.comWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American public. He says this is much more serious than anything he's ever predicted before. (And, keep in mind, this is the man who has called almost every crash in recent history... including 2008, 2020, and 2022.) The real truth about the recent selloffs, Dan says, is much bigger - and much worse - than the public realizes.March 12, 2025 | Stansberry Research (Ad)Column-China's Failure to Fire Policy Bazooka May Keep Markets in Deep Freeze: McGeeverSeptember 24, 2024 | money.usnews.comChina's failure to fire policy bazooka may keep markets in deep freeze: McGeeverSeptember 24, 2024 | msn.comChina CNPC's global oil, gas investmentAugust 27, 2024 | reuters.comHEADLINES: China protests PCG flagship in PH waters | August 18, 2024August 18, 2024 | msn.comHow FTC's Battle With PBMs Could Reshape The Pharmaceutical IndustryJuly 23, 2024 | forbes.comSee More Headlines FCPG Stock Analysis - Frequently Asked Questions How do I buy shares of First China Pharmaceutical Group? Shares of FCPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of First China Pharmaceutical Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that First China Pharmaceutical Group investors own include SES AI (SES), American Heritage International (AHII), Affinity Networks (AFFN), Astera Labs (ALAB), Akoustis Technologies (AKTS) and American Battery Technology (ABAT). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorManufacturing Industry Electronic Computer Manufacturing Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:FCPG CIK1432254 Webwww.firstchinapharma.com Phone+86-852-21381668FaxN/AEmployees147,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Top Nuclear Stocks To Buy NowNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (OTCMKTS:FCPG) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredMagnificent 7 wipeout: What's next?A massive wave of volatility is sweeping the stock market... After the recent selloff, the "Magnificent Sev...Chaikin Analytics | SponsoredWarren Buffet Just Made a $334 Billion BetDebt is out of control. Inflation is creeping back. And a major market downturn could be right around the corn...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First China Pharmaceutical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share First China Pharmaceutical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.